Neutral impactResults
Dr Lal PathLabs Q2 net profit rises 27.5% to ₹194 cr on volume growth
Business Standard 1 hr ago·4 Nov 2026, 2:10 pm
Dr Lal PathLabs reported a 19.6 per cent rise in Q2FY27 revenue to ₹874 crore as sample volumes grew 13.6 per cent and patient coverage increased 9 per cent
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns DR. LAL Path Labs (LALPATHLAB).
- Category: Results.
Why it matters
A routine update for DR. LAL Path Labs. Use the price and stock snapshot to gauge how the market is responding.
